Tower Research Capital LLC (Trc) Cyteir Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$2.84 - $3.13 $10,985 - $12,106	-3,868 Reduced 55.92%	3,049 $9,000
Q3 2023 Nov 14, 2023	BUY	$2.71 - $2.84 $14,121 - $14,799	5,211 Added 305.45%	6,917 $19,000
Q2 2023 Aug 14, 2023	BUY	$1.74 - $2.6 $2,968 - $4,435	1,706 New	1,706 $4,000
Q3 2022 Nov 10, 2022	SELL	$1.99 - $4.05 $280 - $571	-141 Reduced 2.35%	5,859 $11,000
Q2 2022 Aug 15, 2022	BUY	$1.62 - $4.4 $2,336 - $6,344	1,442 Added 31.64%	6,000 $18,000
Q1 2022 May 12, 2022	BUY	$3.39 - $10.51 $8,068 - $25,013	2,380 Added 109.27%	4,558 $17,000
Q4 2021 Feb 14, 2022	BUY	$9.83 - $19.21 $17,507 - $34,213	1,781 Added 448.61%	2,178 $25,000
Q3 2021 Nov 15, 2021	BUY	$14.57 - $21.86 $5,784 - $8,678	397 New	397 $7,000

2.47M

Ticker CYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,413,400
Market Cap $107M
Description
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.